216 related articles for article (PubMed ID: 26209187)
21. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Jayaprabhu S; Pecorelli S; Parham GP; Cannon MJ
Clin Cancer Res; 2001 Mar; 7(3 Suppl):804s-810s. PubMed ID: 11300476
[TBL] [Abstract][Full Text] [Related]
22. A comparison of the cytolytic properties of murine primary CD8+ cytotoxic T lymphocytes and cloned cytotoxic T cell lines.
Nagler-Anderson C; Allbritton NL; Verret CR; Eisen HN
Immunol Rev; 1988 Mar; 103():111-25. PubMed ID: 3134291
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
[TBL] [Abstract][Full Text] [Related]
24. Rapid deletion and inactivation of CTLs upon recognition of a number of target cells over a critical threshold.
Prato S; Zhan Y; Mintern JD; Villadangos JA
J Immunol; 2013 Oct; 191(7):3534-44. PubMed ID: 24018271
[TBL] [Abstract][Full Text] [Related]
25. Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function.
Gropper Y; Feferman T; Shalit T; Salame TM; Porat Z; Shakhar G
Cell Rep; 2017 Sep; 20(11):2547-2555. PubMed ID: 28903036
[TBL] [Abstract][Full Text] [Related]
26. Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytes.
Walden PR; Eisen HN
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9015-9. PubMed ID: 2123347
[TBL] [Abstract][Full Text] [Related]
27. Limited transplantation of antigen-expressing hematopoietic stem cells induces long-lasting cytotoxic T cell responses.
Denning WL; Xu J; Guo S; Klug CA; Hel Z
PLoS One; 2011 Feb; 6(2):e16897. PubMed ID: 21379572
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia augments MHC class I antigen presentation via facilitation of ERO1-α-mediated oxidative folding in murine tumor cells.
Kajiwara T; Tanaka T; Kukita K; Kutomi G; Saito K; Okuya K; Takaya A; Kochin V; Kanaseki T; Tsukahara T; Hirohashi Y; Torigoe T; Hirata K; Sato N; Tamura Y
Eur J Immunol; 2016 Dec; 46(12):2842-2851. PubMed ID: 27667124
[TBL] [Abstract][Full Text] [Related]
29. Cloned cytotoxic T lymphocyte target cells fail to induce early activation events in effector cytotoxic T lymphocytes.
Ostergaard H; Gorman K; Clark WR
Cell Immunol; 1988 Jun; 114(1):188-97. PubMed ID: 3259474
[TBL] [Abstract][Full Text] [Related]
30. Serine protease inhibitors and cytotoxic T lymphocytes.
Ashton-Rickardt PG
Immunol Rev; 2010 May; 235(1):147-58. PubMed ID: 20536561
[TBL] [Abstract][Full Text] [Related]
31. Reduced CTL motility and activity in avascular tumor areas.
Manaster Y; Shipony Z; Hutzler A; Kolesnikov M; Avivi C; Shalmon B; Barshack I; Besser MJ; Feferman T; Shakhar G
Cancer Immunol Immunother; 2019 Aug; 68(8):1287-1301. PubMed ID: 31253998
[TBL] [Abstract][Full Text] [Related]
32. Experimental evidence that carbon-ion radiotherapy utilizes cytotoxic T lymphocyte-mediated anti-tumor immunity for shrinking tumors compared to X-ray therapy.
Takeshima T; Hirayama R; Hasegawa S
Biochem Biophys Res Commun; 2024 Jul; 718():150058. PubMed ID: 38729076
[TBL] [Abstract][Full Text] [Related]
33. Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models.
Li A; Wu Y; Linnoila J; Pulli B; Wang C; Zeller M; Ali M; Lewandrowski GK; Li J; Tricot B; Keliher E; Wojtkiewicz GR; Fulci G; Feng X; Tannous BA; Yao Z; Chen JW
Cancer Immunol Immunother; 2016 Dec; 65(12):1545-1554. PubMed ID: 27722909
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic lipase-related protein 2 (PLRP2) induction by IL-4 in cytotoxic T lymphocytes (CTLs) and reevaluation of the negative effects of its gene ablation on cytotoxicity.
Alves BN; Leong J; Tamang DL; Elliott V; Edelnant J; Redelman D; Singer CA; Kuhn AR; Miller R; Lowe ME; Hudig D
J Leukoc Biol; 2009 Sep; 86(3):701-12. PubMed ID: 19451396
[TBL] [Abstract][Full Text] [Related]
35. Serine esterase and hemolytic activity in human cloned cytotoxic T lymphocytes.
Ferguson WS; Verret CR; Reilly EB; Iannini MJ; Eisen HN
J Exp Med; 1988 Feb; 167(2):528-40. PubMed ID: 3126252
[TBL] [Abstract][Full Text] [Related]
36. Contact-Dependent Killing by Cytotoxic T Lymphocytes Is Insufficient for EL4 Tumor Regression
Beck RJ; Slagter M; Beltman JB
Cancer Res; 2019 Jul; 79(13):3406-3416. PubMed ID: 31040155
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo.
Halle S; Halle O; Förster R
Trends Immunol; 2017 Jun; 38(6):432-443. PubMed ID: 28499492
[TBL] [Abstract][Full Text] [Related]
38. A simple method to detect Toxoplasma gondii-specific cytotoxic T cells in vivo.
Daniel BJ; Pandeswara S; Brumlik MJ; Liu A; Thibodeaux SR; Ludwig SM; Sun X; Curiel TJ
J Immunol Methods; 2010 Apr; 355(1-2):86-90. PubMed ID: 20149795
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel population of highly cytotoxic c-Met-expressing CD8
Benkhoucha M; Molnarfi N; Kaya G; Belnoue E; Bjarnadóttir K; Dietrich PY; Walker PR; Martinvalet D; Derouazi M; Lalive PH
EMBO Rep; 2017 Sep; 18(9):1545-1558. PubMed ID: 28751311
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxel inhibits killing by murine cytotoxic T lymphocytes in vivo but not in vitro.
Robinson MJ; Ronchese F; Miller JH; La Flamme AC
Immunol Cell Biol; 2010; 88(3):291-6. PubMed ID: 19997079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
